RemSleep Holdings (RMSL) EPS (Basic) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.66% |
| Sep 30, 2025 | -4.45% |
| Jun 30, 2025 | -15.77% |
| Mar 31, 2025 | 50.20% |
| Dec 31, 2024 | -15.12% |
| Sep 30, 2024 | 30.43% |
| Jun 30, 2024 | 73.14% |
| Mar 31, 2024 | 72.98% |
| Dec 31, 2023 | -15.01% |
| Sep 30, 2023 | 68.54% |
| Jun 30, 2023 | 68.60% |
| Mar 31, 2023 | 67.07% |
| Dec 31, 2022 | 57.24% |
| Sep 30, 2022 | 62.67% |
| Jun 30, 2022 | 67.07% |
| Mar 31, 2022 | 27.52% |
| Dec 31, 2021 | -14.87% |
| Sep 30, 2021 | 31.94% |
| Jun 30, 2021 | -38.41% |
| Mar 31, 2021 | -21.93% |
| Dec 31, 2020 | -15.14% |
| Sep 30, 2020 | 1.92% |
| Jun 30, 2020 | 14.99% |
| Mar 31, 2020 | 60.90% |
| Dec 31, 2019 | 37.19% |
| Sep 30, 2019 | -14.97% |
| Jun 30, 2019 | -23.68% |
| Mar 31, 2019 | -24.27% |
| Dec 31, 2018 | 14.91% |
| Sep 30, 2018 | -158.05% |
| Jun 30, 2018 | -37.97% |
| Mar 31, 2018 | -131.35% |
| Dec 31, 2017 | -31.95% |
| Sep 30, 2017 | -81.28% |
| Jun 30, 2017 | -5.92% |
| Mar 31, 2017 | -246.57% |
| Dec 31, 2016 | 77.68% |
| Jun 30, 2016 | -19.89% |
| Mar 31, 2016 | -33.86% |
| Dec 31, 2015 | -21.17% |
| Sep 30, 2015 | 46.44% |